This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
631 |
4. Check minimum number of events
Min. number of events
3
|
631 |
5. Include endpointsNone |
631 |
6. Filter based on genotype QC (FinnGen only) |
631 |
Control definitions (FinnGen only)
- Control exclude
- RX_OPIOIDS
Extra metadata
- First used in FinnGen datafreeze
- DF4
Morphin
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 631 | 242 | 389 |
| Unadjusted period prevalence (%) | 0.14 | 0.08 | 0.17 |
| Median age at first event (years) | 69.57 | 67.57 | 70.82 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 491
- Matched controls
- 4909
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N02AA01
ATC
morphine; systemic, rectal
+∞
323.0
491
6
N02AA05
ATC
oxycodone; systemic
41.5
216.4
282
154
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
41.8
139.0
175
64
A03FA01
ATC
metoclopramide; systemic, rectal
11.6
116.9
262
440
130
Kela drug reimbursment
Malignant tumour
19.0
114.2
186
152
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
79.8
109.1
121
20
Z51.5
ICD-10 Finland
Palliative care
22.3
106.9
162
106
N02AX02
ATC
tramadol; systemic, rectal
7.9
94.0
290
755
A06AD11
ATC
lactulose; oral
6.5
61.7
191
437
N03AX16
ATC
pregabalin; oral
7.2
59.9
166
324
H02AB02
ATC
dexamethasone; systemic
8.3
54.0
131
206
N02AC04
ATC
dextropropoxyphene; oral
17.9
49.6
79
52
A06AH03
ATC
naloxegol; oral
515.3
48.2
47
*
N06AA09
ATC
amitriptyline; systemic
8.4
44.9
106
156
N03AX12
ATC
gabapentin; oral
7.0
41.5
112
200
N05AD01
ATC
haloperidol; systemic
12.1
41.0
77
74
H02AB06
ATC
prednisolone; systemic
3.5
37.3
285
1398
N06AX21
ATC
duloxetine; oral
8.4
36.4
84
117
A04AA01
ATC
ondansetron; systemic, rectal
9.8
32.7
68
79
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
14.2
32.5
56
44
A04AA02
ATC
granisetron; systemic, transdermal
9.4
30.9
66
80
N05BA04
ATC
oxazepam; oral
3.6
30.2
165
598
WF049
NOMESCO Finland
Radiotherapy of metastasis
13.1
28.7
51
43
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.3
28.6
81
150
C03CA01
ATC
furosemide; systemic
2.9
26.7
238
1201
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
26.5
127
408
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
26.1
185
801
N02AA03
ATC
hydromorphone; systemic, rectal
274.1
25.9
26
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.4
25.9
83
178
JN4BD
NOMESCO Finland
Extensive body CT
4.7
25.9
96
242
N05CF01
ATC
zopiclone; oral
2.9
25.8
210
995
N06AX11
ATC
mirtazapine; oral
3.1
25.8
180
768
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
24.5
197
918
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.8
23.6
85
207
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.4
23.5
53
70
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.9
23.0
50
62
N02AJ06
ATC
codeine and paracetamol; systemic
3.3
21.9
128
474
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
12.0
21.8
40
36
N07BC02
ATC
methadone; systemic
229.7
21.8
22
*
J96.1
ICD-10 Finland
Chronic respiratory failure
9.4
21.6
45
52
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
27.9
21.6
29
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
21.3
233
1277
N05CD07
ATC
temazepam; oral
3.4
21.1
114
396
J01MA12
ATC
levofloxacin; systemic
3.2
20.9
129
493
R06.0
ICD-10 Finland
Dyspnoea
2.9
20.6
152
657
M01AE03
ATC
ketoprofen; systemic, rectal
2.6
20.4
210
1102
N06AX16
ATC
venlafaxine; oral
4.6
20.2
74
182
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.8
20.1
71
168
R03BB04
ATC
tiotropium bromide; inhalant
3.5
19.4
98
322
ZX070
NOMESCO Finland
Intensity modified radiotherapy
13.0
19.4
34
28
SPAT1109
SPAT
Analgesia with portable analgesic pump
72.8
18.8
21
*
N05BA01
ATC
diazepam; systemic, rectal
3.6
18.8
94
306
L01CA04
ATC
vinorelbine; systemic
40.1
18.7
23
6
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
40.1
18.7
23
6
A07AA02
ATC
nystatin; oral
5.8
18.5
54
103
A02BC01
ATC
omeprazole; systemic
2.6
18.3
171
840
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
18.2
75
206
N05AA02
ATC
levomepromazine; systemic
7.1
18.1
45
69
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
18.0
161
770
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.8
18.0
52
98
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
17.7
87
278
N05BA06
ATC
lorazepam; systemic, sublingual
5.4
17.6
54
109
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.1
17.6
109
414
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
17.5
87
281
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.9
17.5
59
133
N03AX09
ATC
lamotrigine; oral
9.8
17.4
35
38
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.2
17.3
47
82
M05BA02
ATC
clodronic acid; systemic
32.8
17.2
22
7
N03AE01
ATC
clonazepam; systemic
5.9
17.0
48
88
TGD00
NOMESCO Finland
Needle biopsy of lung
36.4
16.8
21
6
R52.1
ICD-10 Finland
Chronic intractable pain
93.2
16.7
18
*
B01AB10
ATC
tinzaparin; parenteral
4.8
16.5
56
127
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
41.6
16.4
20
5
R52.2
ICD-10 Finland
Other chronic pain
10.9
16.4
31
30
JN4AD
NOMESCO Finland
Body CT examination
4.1
16.2
65
174
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.2
15.9
50
104
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
15.9
105
415
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.6
15.7
30
30
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.7
15.5
45
85
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
16.7
15.4
24
15
SPAT1229
SPAT
Assessment of need for aid
4.1
15.1
61
164
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
5.7
14.9
43
81
R28
ICPC
Limited function/disability (R)
17.1
14.9
23
14
348
Kela drug reimbursment
Roflumilast
82.6
14.6
16
*
R03AC02
ATC
salbutamol; inhalant
2.2
14.6
236
1476
L01XX11
ATC
estramustine; systemic
37.2
14.5
18
5
A01
ICPC
Pain general/multiple sites
4.7
14.4
50
116
WF004
NOMESCO Finland
Palliative radiotherapy
13.9
14.3
24
18
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
23.1
14.3
20
9
SPAT1255
SPAT
Intravenous administration of medicine
4.6
14.3
50
117
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.6
14.0
30
37
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.2
13.8
43
89
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
7.4
13.6
32
46
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
13.5
123
580
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
13.5
113
509
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
14.3
13.4
22
16
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
14.3
13.4
22
16
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
13.3
209
1276
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
12.8
37
70
SPAT1254
SPAT
Administration of medicine
2.8
12.8
91
373
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
12.8
68
230
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
12.7
113
525
R50.9
ICD-10 Finland
Fever, unspecified
2.9
12.6
83
323
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
8.0
12.6
28
37
WX721
NOMESCO Finland
Oxygen concentrator therapy
+∞
12.5
12
*
WX725
NOMESCO Finland
Noninvasive ventilation
5.6
12.5
36
68
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.7
12.4
28
38
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
12.3
43
101
A02BC02
ATC
pantoprazole; systemic
2.0
12.3
288
2039
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.1
12.0
38
80
N07BA03
ATC
varenicline; oral
6.8
11.7
29
45
R84
ICPC
Malignant neoplasm bronchus/lung
66.5
11.7
13
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
14.1
11.5
19
14
N06AB10
ATC
escitalopram; oral
2.7
11.4
84
351
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
35.9
11.3
14
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
25.7
11.2
15
6
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
11.5
11.1
20
18
WZC30
NOMESCO Finland
Teaching
3.0
11.1
68
253
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.0
11.1
44
117
ZX080
NOMESCO Finland
Image guided radiotherapy
10.4
11.1
21
21
N05BA12
ATC
alprazolam; oral
3.3
10.9
57
190
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
8.6
10.9
23
28
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.4
10.9
39
94
N05AH04
ATC
quetiapine; oral
2.7
10.9
78
320
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
15.9
10.9
17
11
N06AB04
ATC
citalopram; systemic
2.3
10.9
109
533
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
10.9
10.9
20
19
B01AB05
ATC
enoxaparin; parenteral
2.1
10.8
137
749
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.6
10.8
27
43
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
5.7
10.7
30
55
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.0
10.7
29
51
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.3
10.7
23
29
R03DX07
ATC
roflumilast; oral
61.3
10.7
12
*
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
61.3
10.7
12
*
N06AX03
ATC
mianserin; oral
4.7
10.7
36
82
M54.1
ICD-10 Finland
Radiculopathy
6.6
10.5
26
41
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
+∞
10.4
10
*
J94.8
ICD-10 Finland
Other specified pleural conditions
8.5
10.4
22
27
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
10.4
90
407
M01AX17
ATC
nimesulide; oral
2.2
10.4
122
643
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
7.4
10.4
24
34
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
10.4
90
409
M01AH02
ATC
rofecoxib; oral
2.7
10.3
71
285
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.7
10.3
34
76
N06AX12
ATC
bupropion; oral
6.1
10.3
27
46
M01AH01
ATC
celecoxib; oral (coxibs)
2.5
10.1
86
385
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.6
10.1
18
16
A04AD12
ATC
aprepitant; systemic
11.6
10.1
18
16
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
9.4
10.1
20
22
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
12.5
9.9
17
14
R02
ICPC
Shortness of breath/dyspnoea
2.9
9.9
64
245
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.4
9.9
35
84
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.6
9.8
33
75
R95
ICPC
Chron obstructive pulmonary disease
5.8
9.8
27
49
A01AB09
ATC
miconazole; local oral
3.0
9.8
56
199
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
9.7
142
819
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
9.7
104
524
JDB10
NOMESCO Finland
Percutaneous gastrostomy
13.7
9.7
16
12
SPAT1262
SPAT
Handing over of treatment supplies
2.2
9.6
104
528
M01AE51
ATC
ibuprofen, combinations; systemic
11.7
9.6
17
15
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
30.7
9.4
12
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
9.3
76
332
M03BC01
ATC
orphenadrine (citrate); systemic
2.5
9.3
79
356
A02BX02
ATC
sucralfate; oral
4.0
9.2
36
95
A02BA02
ATC
ranitidine; systemic
2.1
9.2
112
597
M05BX04
ATC
denosumab; parenteral
4.4
9.2
32
76
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
9.1
92
450
M54.4
ICD-10 Finland
Lumbago with sciatica
2.9
9.1
57
215
N06AA12
ATC
doxepin; systemic
4.0
9.0
35
92
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
5.7
9.0
25
46
XG466
NOMESCO Finland
Sleep oxymetry
5.1
8.9
27
55
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
24.5
8.9
12
5
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.3
8.9
32
78
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.3
8.9
26
51
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
8.8
8.9
18
21
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
8.8
76
343
M48.0
ICD-10 Finland
Spinal stenosis
2.9
8.8
54
199
L28
ICPC
Limited function/disability (L)
2.3
8.8
88
429
M01AE02
ATC
naproxen; oral, rectal
1.8
8.8
218
1507
L01BC06
ATC
capecitabine; oral
5.2
8.8
26
52
M54.3
ICD-10 Finland
Sciatica
4.8
8.7
28
61
TAC99
NOMESCO Finland
Other blockade for chronic pain
14.4
8.7
14
10
A46
ICD-10 Finland
Erysipelas
2.5
8.7
72
318
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
16.6
8.6
13
8
R60.0
ICD-10 Finland
Localized oedema
2.7
8.6
58
230
N03AF02
ATC
oxcarbazepine; oral
4.9
8.6
27
58
J01MA14
ATC
moxifloxacin; systemic
3.0
8.5
49
175
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
28.0
8.5
11
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
8.5
81
386
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
91.5
8.4
9
*
S97
ICPC
Chronic ulcer skin
3.8
8.4
34
93
M54.5
ICD-10 Finland
Low back pain
2.0
8.3
114
637
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
7.3
8.3
19
27
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
8.3
30
74
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.3
8.3
41
132
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
8.3
80
383
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
5.0
8.2
25
52
J01FF01
ATC
clindamycin; systemic
2.0
8.2
119
678
A02BC05
ATC
esomeprazole; systemic
1.8
8.1
166
1070
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
17.5
8.1
12
7
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.5
8.1
27
62
R03AK07
ATC
formoterol and budesonide; inhalant
2.3
8.0
80
387
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.0
8.0
31
82
JN4CD
NOMESCO Finland
Very extensive body CT
4.1
8.0
30
77
M01AB55
ATC
diclofenac, combinations; oral
3.1
8.0
42
142
R03DA04
ATC
theophylline; systemic, rectal
2.8
8.0
51
196
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.8
8.0
19
29
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.3
7.9
13
10
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.9
7.9
21
37
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.2
7.9
29
73
N03AF01
ATC
carbamazepine; oral, rectal
3.3
7.9
39
126
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.1
7.9
44
152
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
7.7
44
156
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.1
7.6
13
11
180
Kela drug reimbursment
Interferon alfa
25.4
7.6
10
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
25.4
7.6
10
*
A03FA02
ATC
cisapride; oral, rectal
2.7
7.6
51
200
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
9.1
7.6
15
17
C03DA01
ATC
spironolactone; oral
2.3
7.5
68
316
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.5
7.3
56
237
SPAT1111
SPAT
Planning of analgesia
9.6
7.3
14
15
N06AA10
ATC
nortriptyline; systemic
9.6
7.3
14
15
A02BA03
ATC
famotidine; systemic
3.4
7.3
34
106
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
7.2
53
222
H02AB04
ATC
methylprednisolone; systemic
2.3
7.2
70
335
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
20.4
7.2
10
5
R03AC18
ATC
indacaterol; inhalant
20.4
7.2
10
5
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
5.4
7.1
20
38
N02BE51
ATC
paracetamol, combinations excl. psycholeptics; systemic
9.0
7.1
14
16
N06AA04
ATC
clomipramine; systemic
9.0
7.1
14
16
SPAT1263
SPAT
Sampling
1.7
7.1
180
1231
M03BX01
ATC
baclofen; systemic
7.1
7.0
16
23
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
7.1
7.0
16
23
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
7.0
58
258
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.0
154
1009
H02AB07
ATC
prednisone; oral
2.2
7.0
71
347
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
6.9
49
201
284
Kela drug reimbursment
Nintedanib and pirfenidone
14.0
6.9
11
8
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
4.3
6.9
24
58
TGC00
NOMESCO Finland
Bronchial lavation
5.2
6.9
20
40
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.4
6.9
14
17
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.1
6.8
12
11
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
6.2
6.8
17
28
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
40.6
6.8
8
*
L04AX05
ATC
pirfenidone; oral
17.0
6.8
10
6
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
22.9
6.7
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
6.6
6.7
16
25
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.7
6.7
21
46
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.0
6.6
14
18
J01MA01
ATC
ofloxacin; systemic
2.5
6.6
52
225
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.2
6.6
19
38
L86
ICPC
Back syndrome with radiating pain
4.6
6.5
21
47
R03BA01
ATC
beclometasone; inhalant
2.2
6.5
66
322
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.8
6.5
17
30
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
6.5
37
132
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
7.5
6.4
14
19
SPAT1240
SPAT
Therapeutic discussion
2.9
6.4
37
133
L03AA04
ATC
NA
70.7
6.4
7
*
WX892
NOMESCO Finland
Monitored bed care
2.9
6.4
38
140
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.0
6.4
19
39
A98
ICPC
Health maint/preventive medicine
0.6
6.4
293
3482
A02BC03
ATC
lansoprazole; oral
1.8
6.4
126
794
R03BA05
ATC
fluticasone; inhalant
2.1
6.4
76
400
N06AG02
ATC
moclobemide; oral
4.0
6.4
24
63
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.8
6.4
121
752
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
6.3
45
186
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
18.3
6.3
9
5
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
+∞
6.3
6
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
+∞
6.3
6
*
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
+∞
6.3
6
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
27.0
6.2
8
*
L01CB01
ATC
etoposide; systemic
27.0
6.2
8
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
27.0
6.2
8
*
E0000UV
ATC
NA
1.7
6.2
157
1067
A02BA04
ATC
nizatidine; systemic
2.4
6.2
50
221
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
7.8
6.2
13
17
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.1
6.1
31
104
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.8
6.1
24
66
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.2
6.1
11
11
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.1
181
1285
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.7
6.0
16
29
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.1
6.0
31
105
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
112
90
14.91
117.68
10.1
5.0
3.2
2.6
mmol/l
1.01
101
65
87
47
21.31
111.88
2.7
2.1
87.5
89.2
%
0.95
87
47
102
90
13.33
100.84
3.8
2.3
15.6
16.2
%
0.41
40
52
63
52
13.35
64.26
2.1
1.5
—
—
—
0
0
52
31
18.19
63.23
2.1
1.3
—
—
—
0
0
81
99
9.24
62.97
1.6
1.4
—
—
—
0
0
70
71
10.96
62.44
2.2
1.5
—
—
—
0
0
41
17
25.72
58.00
1.9
1.4
—
—
—
0
0
76
95
8.96
57.93
2.2
1.5
—
—
—
0
0
55
44
13.60
57.04
2.3
1.4
—
—
—
0
0
41
18
24.29
56.75
1.9
1.3
—
—
—
0
0
75
102
8.21
53.26
2.2
1.4
—
—
—
0
0
58
57
11.10
52.71
1.4
1.1
—
—
—
0
0
55
53
11.27
50.62
1.9
1.4
—
—
—
0
0
41
24
18.20
50.10
1.9
1.3
—
—
—
0
0
53
50
11.48
49.45
1.9
1.5
—
—
—
0
0
57
60
10.34
49.32
3.3
2.8
5.0
4.9
e9/l
0.09
57
60
57
60
10.34
49.32
3.6
3.1
63.1
62.9
%
0.04
57
60
163
485
4.18
49.26
8.1
3.1
—
—
—
0
0
58
64
9.88
48.48
1.8
1.4
—
—
—
0
0
193
654
3.81
48.40
5.0
2.9
0.8
0.8
mmol/l
2.06
182
615
55
57
10.47
48.10
1.9
1.4
—
—
—
0
0
96
192
5.72
47.00
1.6
1.8
1.1
1.9
ug/l
0.53
79
172
205
757
3.53
44.69
2.9
1.7
—
—
—
0
0
31
17
19.13
38.87
3.3
2.9
—
—
—
0
0
76
149
5.66
37.78
2.4
3.0
—
—
—
0
0
95
243
4.43
34.43
1.7
1.4
—
—
—
0
0
100
284
4.00
31.39
7.7
3.7
4.2
2.0
mmol/l
5.20
85
212
101
308
3.71
28.52
7.7
3.6
5.8
5.2
kpa
4.82
96
285
366
2239
2.51
27.88
11.7
5.1
9.6
12.3
umol/l
6.19
354
2120
100
316
3.57
26.70
4.2
1.6
307.6
395.5
nmol/l
3.56
94
286
135
532
2.96
24.90
2.7
1.6
—
—
—
0
0
170
783
2.60
23.05
2.1
1.6
1.1
1.4
mg/l
0.93
140
616
303
1816
2.29
22.64
7.8
3.7
39.4
64.6
ng/l
0.67
269
1382
129
530
2.80
21.82
2.6
1.6
—
—
—
0
0
126
517
2.80
21.33
7.5
5.6
2.4
1.3
mmol/l
2.58
110
397
44
91
5.12
20.43
1.4
1.3
—
—
—
0
0
48
108
4.73
20.20
1.9
1.5
—
—
—
0
0
324
2063
2.17
20.10
9.0
4.9
1.2
1.2
mmol/l
4.02
305
1815
26
32
8.43
19.76
1.7
1.7
—
—
—
0
0
259
1531
2.17
19.21
4.6
3.0
1737.4
1871.3
ng/l
0.18
233
1326
351
2352
2.11
18.53
18.2
7.3
4.9
4.3
e9/l
4.74
338
2017
304
1943
2.09
18.08
7.3
5.0
21.9
26.5
%
10.35
295
1783
114
486
2.64
17.71
4.1
3.8
18.6
12.8
ug/l
0.33
101
411
378
2647
2.07
17.21
8.6
4.0
6.9
6.9
mmol/l
0.05
371
2469
81
293
3.02
17.09
1.6
1.5
—
—
—
0
0
299
1943
2.02
16.55
6.2
4.1
31.8
35.0
g/l
20.25
284
1789
242
1478
2.03
15.74
4.1
3.0
2.3
2.4
mmol/l
2.63
215
1250
331
2271
1.96
15.27
9.4
5.6
1.2
1.2
mmol/l
4.06
206
1878
201
1169
2.06
14.79
5.2
3.8
0.0
0.0
estimate
0.00
115
368
210
1246
2.03
14.59
3.6
3.0
0.6
0.5
e6/l
0.31
186
942
347
4420
0.52
13.97
4.1
5.2
2.5
2.6
mmol/l
1.96
276
3961
216
1318
1.97
13.70
4.2
2.1
51.5
61.0
u/l
3.02
200
1205
45
131
3.62
13.43
1.2
1.2
—
—
—
0
0
13
11
12.05
12.67
1.2
1.1
—
—
—
0
0
339
4305
0.54
12.66
3.8
4.6
4.4
4.5
mmol/l
1.58
266
3884
133
699
2.14
12.57
2.5
2.3
10.8
12.9
umol/l
3.35
123
641
250
1640
1.87
12.50
3.7
3.1
—
—
—
0
0
117
604
2.15
11.51
2.6
2.3
20.0
23.3
%
2.01
103
518
340
4265
0.56
11.30
3.8
4.6
1.4
1.5
mmol/l
1.74
265
3816
121
640
2.10
11.16
2.6
2.3
2.3
2.3
g/l
0.35
109
595
51
1169
0.39
10.14
1.6
1.6
1.6
1.3
mmol/l
1.35
46
936
82
387
2.29
9.99
1.9
2.3
65.4
66.3
g/l
0.43
76
356
240
1642
1.74
9.88
4.9
3.9
—
—
—
0
0
14
7
20.41
9.84
1.4
1.6
—
—
—
0
0
83
402
2.23
9.50
2.2
1.9
0.2
0.2
g/l
0.30
78
373
338
4173
0.59
9.43
6.1
6.2
41.6
40.7
mmol/mol
1.02
280
3778
357
4335
0.59
9.14
5.0
4.9
6.0
6.1
mmol/l
0.24
296
3860
179
1152
1.77
8.97
2.2
2.0
3.5
3.1
mg/l
1.31
150
950
335
4122
0.60
8.89
3.6
4.1
1.4
1.2
mmol/l
2.45
258
3662
370
2900
1.67
8.82
6.5
4.3
3301.1
3337.3
e6/l
0.00
11
63
160
1004
1.80
8.70
2.5
1.7
1423.1
1158.4
nmol/l
2.85
117
726
15
25
6.12
8.68
1.4
1.9
—
—
—
0
0
279
2076
1.62
7.87
4.9
3.6
0.0
0.0
estimate
0.00
131
378
19
44
4.42
7.73
2.3
1.7
—
—
—
0
0
18
40
4.60
7.69
2.3
1.7
—
—
—
0
0
277
2079
1.59
7.41
5.9
4.8
0.0
0.0
estimate
0.00
130
380
45
187
2.51
7.27
3.2
1.7
—
—
—
0
0
279
2106
1.58
7.23
5.0
3.6
0.0
0.0
estimate
0.50
126
371
137
863
1.75
7.23
5.3
2.7
2.5
2.5
mmol/l
6.87
127
750
17
39
4.45
7.00
2.2
2.5
—
—
—
0
0
101
590
1.85
6.83
5.7
4.8
1.1
1.0
mmol/l
1.05
93
532
40
164
2.54
6.65
4.2
3.1
117.7
934.2
u/ml
0.48
33
140
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
152
2.60
6.64
2.6
2.5
0.4
0.4
u/ml
0.10
23
89
41
171
2.49
6.59
3.0
1.6
—
—
—
0
0
22
65
3.47
6.47
1.4
1.6
—
—
—
0
0
19
53
3.67
6.08
1.7
1.4
314313.3
34683.2
e6/l
0.45
12
33
403
3379
1.53
6.06
16.0
6.2
85.1
77.6
u/l
3.00
389
3107
12
23
5.30
6.03
1.2
1.3
—
—
—
0
0
158
1082
1.61
5.97
1.8
1.7
76859986.4
6574824.3
pmol/l
0.44
121
867
27
100
2.78
5.50
1.3
1.3
253.6
329.5
ug/g
1.18
17
53
177
1270
1.55
5.42
6.0
2.9
30.6
36.6
u/l
1.38
164
1208
20
64
3.19
5.23
1.7
1.5
30.9
32.5
pg
0.95
20
64
114
1664
0.62
5.19
4.1
4.5
20.2
22.1
%
0.80
50
884
19
60
3.23
5.08
2.0
4.0
1.8
1.2
%
0.27
14
45
11
23
4.85
5.03
1.2
1.3
—
—
—
0
0
15
41
3.72
4.95
1.9
1.5
—
—
—
0
0
15
41
3.72
4.95
1.9
1.5
—
—
—
0
0
15
41
3.72
4.95
1.9
1.5
—
—
—
0
0
13
32
4.13
4.92
1.1
1.3
—
—
—
0
0
7
5
14.13
4.58
1.6
1.0
36.9
71.4
umol/l
—
7
5
434
4813
0.69
4.44
53.8
20.1
126.4
134.7
g/l
22.22
426
4691
434
4812
0.69
4.42
52.9
20.0
4.2
4.5
e12/l
14.05
425
4612
176
1310
1.48
4.41
2.9
2.1
131.2
283.1
u/l
1.79
157
1222
6
229
0.25
4.14
1.2
1.7
—
—
—
0
0
77
1175
0.61
4.10
3.1
3.2
0.7
0.9
ug/l
2.07
50
822
21
82
2.61
3.92
2.1
1.2
—
—
—
0
0
21
82
2.61
3.92
2.1
1.2
—
—
—
0
0
72
452
1.67
3.79
3.7
2.4
14.2
8.4
umol/l
0.80
59
404
50
286
1.81
3.64
2.6
1.6
—
—
—
0
0
210
1666
1.39
3.60
3.0
2.5
172.9
154.7
ug/l
0.51
191
1499
247
2022
1.36
3.46
3.0
2.3
—
—
—
0
0
421
4630
0.73
3.39
20.1
9.5
23.5
25.1
u/l
0.82
404
4389
349
3933
0.75
3.20
6.1
4.4
2.1
2.4
mu/l
0.43
299
3474
6
8
7.56
3.06
1.2
1.3
—
—
—
0
0
9
21
4.33
3.00
1.0
1.2
—
—
—
0
0
82
563
1.52
3.00
1.2
1.2
31.0
41.5
iu/ml
0.41
24
169
12
40
3.04
2.98
1.3
1.3
—
—
—
0
0
8
18
4.49
2.80
1.3
1.3
—
—
—
0
0
8
18
4.49
2.80
1.3
1.3
—
—
—
0
0
12
44
2.76
2.56
1.3
1.4
—
—
—
0
0
12
44
2.76
2.56
1.3
1.4
—
—
—
0
0
373
4112
0.77
2.55
37.2
13.2
75.3
73.5
ml/min/173m2
0.85
335
3346
12
45
2.70
2.46
1.3
1.4
—
—
—
0
0
12
45
2.70
2.46
1.3
1.1
1.5
1.7
u/ml
—
6
16
12
45
2.70
2.46
2.1
2.3
782.0
593.9
ml
—
5
30
12
45
2.70
2.46
1.3
1.4
—
—
—
0
0
12
45
2.70
2.46
1.3
1.4
—
—
—
0
0
17
77
2.24
2.39
1.2
1.3
—
—
—
0
0
12
46
2.64
2.37
1.3
1.4
—
—
—
0
0
61
416
1.52
2.33
4.0
3.2
2.7
2.1
mmol/l
0.70
52
325
431
4644
0.77
2.31
42.0
16.5
4.0
4.0
mmol/l
1.25
422
4483
7
18
3.92
2.25
1.7
1.5
—
—
—
0
0
7
18
3.92
2.25
1.7
1.5
—
—
—
0
0
7
18
3.92
2.25
1.7
1.5
—
—
—
0
0
36
218
1.69
2.24
5.4
3.6
46.6
46.5
%
0.01
36
213
8
24
3.36
2.18
2.9
2.7
—
—
—
0
0
431
4630
0.78
2.14
41.9
16.4
138.6
139.8
mmol/l
14.09
422
4468
126
1566
0.76
2.10
4.1
3.9
13.9
7.9
mg/mmol
0.74
77
994
22
117
1.91
2.08
4.3
3.1
0.9
0.9
nmol/l
0.01
17
97
11
44
2.53
2.02
6.8
3.5
—
—
—
0
0
8
26
3.10
2.02
1.1
1.1
—
—
—
0
0
173
2052
0.78
2.00
4.8
5.2
2.4
3.0
ug/l
0.49
134
1802
24
408
0.57
1.97
1.2
1.4
—
—
—
0
0
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
134
1085
1.30
1.89
2.7
2.6
17289.6
12144.2
umol/l
0.15
106
916
5
12
4.19
1.82
1.0
1.1
34.4
27.8
%
—
5
5
10
41
2.46
1.76
1.1
1.1
—
—
—
0
0
220
1906
1.24
1.76
5.4
3.6
—
—
—
0
0
47
324
1.49
1.75
2.1
1.7
1.9
1.6
%
1.05
37
263
349
3173
1.22
1.74
5.3
3.7
21.9
13.4
mm/h
10.52
318
2837
11
48
2.31
1.71
1.3
1.1
3.8
3.0
u/ml
—
5
21
19
104
1.85
1.69
1.5
2.3
3.7
3.6
g/l
0.03
19
97
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
6
21
2.87
1.51
2.0
1.1
4.8
8.4
u/l
—
6
14
70
540
1.33
1.42
1.2
1.2
20.9
15.5
u/ml
0.10
15
194
6
23
2.62
1.37
1.7
1.3
0.1
0.2
nmol/l
—
6
14
11
54
2.06
1.33
2.4
2.7
—
737.4
—
0
5
32
217
1.50
1.33
3.5
2.2
1.7
1.1
%
1.52
32
217
47
345
1.39
1.31
4.1
2.6
4.0
4.3
kpa
0.71
47
332
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
8
35
2.30
1.27
1.0
1.1
—
—
u/ml
—
0
0
11
56
1.98
1.22
3.3
3.1
—
20.7
—
0
13
5
19
2.64
1.22
1.0
3.2
232.2
204.8
u/l
—
5
19
13
71
1.85
1.20
1.2
1.1
—
—
—
0
0
18
109
1.67
1.20
1.6
1.5
—
—
—
0
0
12
64
1.89
1.18
1.9
1.4
46.9
45.2
nmol/l
0.08
12
59
0
33
0.00
1.16
0.0
1.4
—
—
—
0
0
57
441
1.32
1.16
3.5
2.3
4.6
6.8
ug/l
0.65
51
389
12
65
1.86
1.14
1.6
1.4
—
—
—
0
0
8
40
2.01
1.12
2.3
3.4
7.5
5.7
nmol/l
—
8
40
47
605
0.76
1.04
3.3
4.6
40.3
32.8
%
1.93
25
361
44
334
1.34
1.03
4.4
3.0
55.8
59.0
ml/min/173m2
0.23
22
143
9
49
1.85
0.99
1.2
1.0
—
—
—
0
0
355
3764
0.87
0.97
28.0
14.9
36.5
38.8
%
2.14
143
2369
12
69
1.75
0.97
1.2
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
6
28
2.15
0.91
2.0
5.1
—
—
—
0
0
11
63
1.76
0.90
1.1
1.3
—
—
—
0
0
77
649
1.21
0.82
27.4
26.5
1.3
1.4
inr
—
7
92
43
339
1.29
0.81
3.6
2.0
34.5
38.1
u/l
0.25
37
286
10
58
1.74
0.80
1.1
1.2
—
14.7
—
0
5
6
107
0.56
0.73
1.2
1.6
—
—
—
0
0
25
332
0.74
0.72
3.2
3.5
102.9
89.9
ng/l
0.13
15
288
34
432
0.77
0.72
1.4
1.3
—
—
—
0
0
10
60
1.68
0.72
5.9
2.8
48.5
21.2
u/ml
—
10
60
7
40
1.76
0.71
1.1
1.1
—
—
—
0
0
269
2521
1.12
0.69
4.4
2.8
80.0
49.5
u/l
1.37
239
2290
70
599
1.19
0.66
18.8
6.7
—
—
—
0
0
13
87
1.50
0.63
1.1
1.1
—
4.3
—
0
9
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
10
65
1.55
0.55
1.5
1.5
148.5
145.2
pmol/l
—
10
65
20
151
1.34
0.54
2.9
2.3
28.7
41.1
mg/l
0.98
15
122
20
151
1.34
0.54
2.9
2.3
136.9
90.2
mg/l
0.30
15
121
11
76
1.46
0.48
4.5
2.0
106.0
105.3
mmol/l
0.21
11
76
11
76
1.46
0.48
4.5
2.0
4.2
4.1
mmol/l
0.09
11
76
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
353.0
—
0
8
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
14
106
1.33
0.39
1.4
1.2
—
—
—
0
0
14
106
1.33
0.39
1.4
1.2
—
—
—
0
0
8
113
0.70
0.37
1.5
1.3
—
—
—
0
0
87
950
0.90
0.37
6.4
3.9
1.0
1.0
kg/l
0.99
14
152
104
971
1.09
0.30
2.8
2.2
—
—
—
0
0
340
3485
0.95
0.26
41.6
16.9
14.7
13.7
%
19.71
333
3387
6
85
0.70
0.24
1.5
1.3
—
—
—
0
0
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
7
94
0.74
0.22
1.0
1.1
—
14.4
—
0
6
13
107
1.22
0.21
1.8
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
191
1975
0.95
0.20
2.1
2.0
93.8
94.2
pmol/l
0.05
110
1003
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
125
1195
1.06
0.20
1.5
1.5
20.6
20.4
nmol/l
0.06
105
997
79
745
1.07
0.19
3.5
2.7
0.9
1.1
e6/l
0.35
52
445
10
81
1.24
0.19
1.0
1.1
—
—
—
0
0
24
213
1.13
0.18
4.7
4.3
2.3
1.6
%
0.68
24
202
13
110
1.19
0.17
1.7
2.1
7.3
12.2
mg/l
1.78
13
102
94
898
1.05
0.16
5.3
3.8
169.8
353.9
ng/l
0.63
77
773
14
160
0.87
0.14
1.0
1.0
—
—
—
0
0
17
191
0.89
0.14
1.0
1.2
139.2
122.6
iu/ml
—
5
68
75
716
1.05
0.13
3.5
3.0
2.4
1.8
e6/l
0.20
49
422
13
148
0.88
0.12
1.4
1.6
—
—
—
0
0
5
47
1.06
0.09
1.2
1.1
1.6
1.5
g/l
—
5
41
12
132
0.91
0.06
1.4
1.5
—
—
—
0
0
17
183
0.93
0.06
2.4
1.7
—
—
—
0
0
13
119
1.09
0.06
4.5
2.4
62.5
90.3
ug/min
—
6
69
14
151
0.93
0.05
1.4
1.3
—
—
—
0
0
29
301
0.96
0.04
2.9
2.8
0.2
0.3
e6/l
0.46
29
296
13
123
1.06
0.01
2.8
1.3
0.0
0.0
g/l
0.00
13
115
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
13
135
0.96
0.00
2.8
1.4
0.0
0.0
g/l
0.00
13
124
13
126
1.03
0.00
2.8
1.3
0.0
0.0
g/l
0.00
13
116
74
737
1.00
0.00
1.3
1.2
0.7
1.4
u/ml
2.00
22
178
172
1723
1.00
0.00
2.5
2.1
76.8
79.4
nmol/l
0.54
145
1502
431
4307
1.00
0.00
41.8
13.3
25.8
27.0
mg/l
0.43
410
3352
317
3173
1.00
0.00
5.3
3.5
15.5
15.0
pmol/l
1.86
280
2782
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.1
—
99.1
—
0
7
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
7
70
1.00
0.00
1.1
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
74.6
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_MORPHIN – Morphin
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).